MedTrace Logo

New Assessment System in Measuring Symptom Distress in Cancer Patients

NCT00505245 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 6500

Last updated 2026-01-21

No results posted yet for this study

Summary

This trial studies how well a new assessment system (MDASI or other MD Anderson-developed PRO instrument) works in measuring symptoms and the impact on quality of life in cancer patients. Development of a new assessment system may provide more information about the common symptoms that may occur in patients due to cancer and its treatment and how the symptoms impact quality of life.

Conditions

  • Caregiver
  • Health Care Provider
  • Malignant Neoplasm
  • Physician

Interventions

OTHER

Interview

Complete interview

OTHER

Quality-of-Life Assessment

Complete quality of life assessment

OTHER

Questionnaire Administration

Complete questionnaires

Sponsors & Collaborators

Principal Investigators

  • Xin Shelley Wang · M.D. Anderson Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1999-04-13
Primary Completion
2031-04-30
Completion
2031-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00505245 on ClinicalTrials.gov